[Preliminary evaluation of an association of polyunsaturated acids in primary hypertriglyceridemia].
The above study was intended to evaluate changes in triglyceride blood level in subjects treated with a polyunsaturated fatty acid combination: docosahexanoic (DHA) and eicosapentaenoic (EPA) acid, compared to changes observed in patients treated with arachidonic acid. The results obtained show that a significant reduction of triglyceride blood level was achieved and was more marked in patients treated with the DHA-EPA combination compared to those treated with arachidonic acid only. An increase in the index of fatty acid unsaturation was observed in all patients without significant differences between treatments.
Marino
O
O
Cattedra di Medicina Interna, Università degli Studi di Roma La Sapienza.
Onofri
E
E
D000328:Adult; D016718:Arachidonic Acid / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology / Q000628:therapy; D004341:Drug Evaluation; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood* / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010169:Palmitic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D005231:Fatty Acids, Unsaturated; D010169:Palmitic Acids; D014280:Triglycerides; D016718:Arachidonic Acid; D015118:Eicosapentaenoic Acid
Prime valutazioni su una associazione di acidi grassi polinsaturi nella ipertrigliceridemia primitiva.